Thermo Fisher Scientific

(

TMO

) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.9%. By the end of trading, Thermo Fisher Scientific fell 58 cents (-1.1%) to $51.34 on average volume. Throughout the day, 1.9 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.3 million shares. The stock ranged in price between $51.11-$52.33 after having opened the day at $52.20 as compared to the previous trading day's close of $51.92. Other company's within the Health Care sector that declined today were:

Biosante Pharmaceuticals

(

BPAX

), down 13%,

NuPathe

(

PATH

), down 12.9%,

Stereotaxis

(

STXS

), down 12.7%, and

Chelsea Therapeutics International

(

CHTP

), down 12%.

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $18.79 billion and is part of the

health services

industry. The company has a P/E ratio of 18.2, below the average health services industry P/E ratio of 18.5 and above the S&P 500 P/E ratio of 17.7. Shares are up 15.5% year to date as of the close of trading on Monday. Currently there are 14 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, attractive valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front,

Amyris

(

AMRS

), up 16.4%,

IsoRay

(

ISR

), up 10.3%,

Fonar Corporation

(

FONR

), up 9.9%, and

CAS Medical Systems

(

CASM

), up 9.7%, were all gainers within the health care sector with

Alexion Pharmaceuticals

(

ALXN

) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null